AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,815,676 | -36.4% | 2,409,289 | +1.7% | 12.25% | -28.7% |
| Q2 2023 | $39,042,585 | +70.6% | 2,369,089 | -5.2% | 17.18% | +46.6% |
| Q1 2023 | $22,889,355 | +27.1% | 2,498,838 | -0.6% | 11.72% | +14.0% |
| Q4 2022 | $18,006,720 | +38.5% | 2,514,905 | -3.1% | 10.28% | +29.3% |
| Q3 2022 | $13,000,000 | +106.2% | 2,594,760 | +0.4% | 7.95% | +109.5% |
| Q2 2022 | $6,305,000 | -61.2% | 2,584,090 | +8.7% | 3.80% | -49.9% |
| Q1 2022 | $16,237,000 | -12.8% | 2,377,290 | +3.1% | 7.58% | -2.0% |
| Q4 2021 | $18,625,000 | – | 2,305,017 | – | 7.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |